Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 11 February 2003
Vol. 2003, Issue 169, p. tw66
[DOI: 10.1126/stke.2003.169.tw66]

EDITORS' CHOICE

PHYSIOLOGY Combating Liver Disease

Protecting the liver, either naturally or therapeutically, is the focus of two reports. Endothelial cells (ECs) were once thought to function primarily in the delivery of nutrients and oxygen to tissues, but recently ECs were shown also to secrete factors that induce organ development in vertebrate embryos before the establishment of blood flow. Studying mouse models, LeCouter et al. (see the Perspective by Davidson and Zon) now show that ECs have a protective function in the adult liver that is independent of their role in new blood vessel growth. In response to activation of vascular endothelial growth factor receptor-1 (VEGFR-1), ECs were shown to secrete several proteins, including hepatocyte growth factor, that stimulate hepatocyte proliferation and reduce tissue damage in a liver injury model. In the search for effective drugs in treating chronic cases of hepatitis B virus, it is important to find drug candidates that target novel aspects of virus physiology. Deres et al. describe a compound, Bay 41-4109, that appears to act by inhibiting the maturation of the viral nucleocapsids.

J. LeCouter, D. R. Moritz, B. Li, G. L. Phillips, X. H. Liang, H.-P. Gerber, K. J. Hillan, N. Ferrara, Angiogenesis-independent endothelial protection of liver: Role of VEGFR-1. Science 299, 890-893 (2003). [Abstract] [Full Text]

A. J. Davidson, L. I. Zon, Love, honor, and protect (your liver). Science 299, 835-837 (2003). [Summary] [Full Text]

K. Deres, C. H. Schröder, A. Paessens, S. Goldmann, H. J. Hacker, O. Weber, T. Krämer, U. Niewöhner, U. Pleiss, J. Stoltefuss, E. Graef, D. Koletzki, R. N. A. Masantschek, A. Reimann, R. Jaeger, R. Groß, B. Beckermann, K.-H. Schlemmer, D. Haebich, H. Rübsamen-Waigmann, Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 299, 893-896 (2003). [Abstract] [Full Text]

Citation: Combating Liver Disease. Sci. STKE 2003, tw66 (2003).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882